Literature DB >> 24241898

Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways.

Madeeha Aqil1, Kim M Elseth, Benjamin J Vesper, Zane Deliu, Bulent Aydogan, Jiaping Xue, James A Radosevich.   

Abstract

Our previous studies demonstrate that A549, a human lung adenocarcinoma line, could be adapted to the free radical nitric oxide (NO([Symbol: see text])). NO([Symbol: see text]) has been shown to be overexpressed in human tumors. The original cell line, A549 (parent), and the newly adapted A549-HNO (which has a more aggressive phenotype) serves as a useful model system to study the role of NO([Symbol: see text]) in tumor biology. It is well known that DNA damage response (DDR) is altered in cancer cells and NO([Symbol: see text]) is known to cause DNA damage. Modulations in molecular mechanisms involved in DNA damage response in A549-HNO cells can provide better insights into the enhanced growth behavior of these cells. Thus, here, we carried out a series of time course experiments by treating A549 and A549-HNO cells with NO([Symbol: see text]) donor and examining levels of proteins involved in the DDR pathway. We observed induced expression of key components of DDR pathway in A549-HNO cells. The HNO cells showed sustained expression of key proteins involved in both nonhomologous end joining (NHEJ) and homologous recombination pathways, whereas parent cells only expressed low levels of NHEJ pathway proteins. Further with prolonged NO([Symbol: see text]) exposure, ATR, Chk1, and p53 were activated and upregulated in HNO cells. Activation of p53 results in inhibition of apoptosis through induced Mcl1 expression. It also leads to cell cycle modulation. Interestingly, several reports show that cancer stem cells have enhanced expression of proteins involved in DNA damage response and also activated an antiapoptotic response. Our results here suggest that our HNO adapted A549 cells have increased activation of DNA damage response pathway proteins which can lead to better DNA repair function. Enhanced DDR leads to activation of antiapoptosis response and modulation in the cell cycle which may lead to better survival of these cells under harsh conditions. Thus, our present investigation further supports the hypothesis that HNO exposure leads to survival of these cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24241898     DOI: 10.1007/s13277-013-1318-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  56 in total

1.  Normalization of cDNA microarray data.

Authors:  Gordon K Smyth; Terry Speed
Journal:  Methods       Date:  2003-12       Impact factor: 3.608

Review 2.  The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

Authors:  Joanne Smith; Lye Mun Tho; Naihan Xu; David A Gillespie
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

3.  Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines.

Authors:  Yaroslav R Yarmolyuk; Benjamin J Vesper; William A Paradise; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-23

4.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

5.  Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck.

Authors:  B G Bentz; G K Haines; M W Lingen; H J Pelzer; D G Hanson; J A Radosevich
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-08       Impact factor: 1.547

6.  Nitric oxide in cigarette smoke as a mediator of oxidative damage.

Authors:  M M Epperlein; J Nourooz-Zadeh; A A Noronha-Dutra; N Woolf
Journal:  Int J Exp Pathol       Date:  1996-10       Impact factor: 1.925

Review 7.  Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining.

Authors:  Chen Wang; Susan P Lees-Miller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-20       Impact factor: 7.038

8.  Part III. Molecular changes induced by high nitric oxide adaptation in human breast cancer cell line BT-20 (BT-20-HNO): a switch from aerobic to anaerobic metabolism.

Authors:  H De Vitto; B S Mendonça; K M Elseth; A Onul; J Xue; B J Vesper; C V M Gallo; F D Rumjanek; W A Paradise; J A Radosevich
Journal:  Tumour Biol       Date:  2012-12-14

Review 9.  A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.

Authors:  Alexander Y Kots; Emil Martin; Iraida G Sharina; Ferid Murad
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

Authors:  Yan Zhao; Huw D Thomas; Michael A Batey; Ian G Cowell; Caroline J Richardson; Roger J Griffin; A Hilary Calvert; David R Newell; Graeme C M Smith; Nicola J Curtin
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

View more
  6 in total

1.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

2.  Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.

Authors:  Birandra K Sinha
Journal:  J Cancer Sci Ther       Date:  2016-10-28

3.  A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.

Authors:  Madeeha Aqil; Kim M Elseth; Ashok Arjunakani; Philip Nebres; Courtney P Amegashie; Devang H Thanki; Premal B Desai; James A Radosevich
Journal:  Tumour Biol       Date:  2014-12-11

4.  DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide.

Authors:  Berna Demircan; Burcu Yucel; James A Radosevich
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 5.  The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention.

Authors:  Huzefa Vahora; Munawwar Ali Khan; Usama Alalami; Arif Hussain
Journal:  J Cancer Prev       Date:  2016-03-30

Review 6.  The Role of Nitric Oxide in Cancer: Master Regulator or NOt?

Authors:  Faizan H Khan; Eoin Dervan; Dibyangana D Bhattacharyya; Jake D McAuliffe; Katrina M Miranda; Sharon A Glynn
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.